Orion Oyj Logo

Orion Oyj

ORNAV | HE

Overview

Corporate Details

ISIN(s):
FI0009014377 (+1 more)
LEI:
74370029VAHCXDR7B745
Country:
Finland
Address:
Orionintie 1, FI-02200 ESPOO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Orion Oyj is a globally operating pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs). The company's research and development activities are focused on translating science into novel therapies, with a primary emphasis on oncology and pain management. Its product portfolio includes proprietary prescription drugs, generic medications, and over-the-counter (OTC) products. With over a century of experience, Orion is dedicated to 'building well-being' by developing innovative treatments and diagnostic tests for a global market.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Orion Oyj. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-20 08:00
Share Issue/Capital Change
337 000 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
Finnish 2.7 KB
2025-08-20 08:00
Share Issue/Capital Change
337,000 Orion Corporation A shares converted into B shares
English 2.8 KB
2025-08-08 08:30
Director's Dealing
Orion Oyj: Johtohenkilöiden liiketoimet - Juhani Kankaanpää
Finnish 4.9 KB
2025-08-08 08:30
Director's Dealing
Orion Corporation: Managers' transactions - Juhani Kankaanpää
English 4.8 KB
2025-08-04 15:10
Director's Dealing
Orion Oyj: Johtohenkilöiden liiketoimet - Satu Ahomäki
Finnish 3.5 KB
2025-08-04 15:10
Director's Dealing
Orion Corporation: Managers' transactions - Satu Ahomäki
English 3.5 KB
2025-07-18 11:00
Interim Report
Orion-konsernin puolivuosikatsaus tammi-kesäkuu 2025
Finnish 18.4 KB
2025-07-18 11:00
Earnings Release
Orion Group Half-Year Financial Report January-June 2025
English 18.3 KB
2025-07-18 08:30
Report Publication Announcement
Orion-konsernin tulosjulkistukset ja yhtiökokous vuonna 2026
Finnish 3.4 KB
2025-07-18 08:30
Report Publication Announcement
Orion Corporation's financial reporting and Annual General Meeting in 2026
English 3.6 KB
2025-07-09 12:00
Management Discussion and Analysis
Sisäpiiritieto: Orion parantaa näkymäarviota vuodelle 2025
Finnish 3.5 KB
2025-07-09 12:00
Earnings Release
Inside information: Orion upgrades full-year outlook for 2025
English 3.6 KB
2025-06-23 08:30
Declaration of Voting Results & Voting Rights Announcements
141 959 kpl Orion Oyj:n A-osaketta muunnettu B-osakkeiksi
Finnish 2.7 KB
2025-06-23 08:30
Declaration of Voting Results & Voting Rights Announcements
141,959 Orion Corporation A shares converted into B shares
English 2.8 KB
2025-05-08 14:30
Major Shareholding Notification
Orion Corporation: Disclosure Under..
Finnish 5.6 KB

Automate Your Workflow. Get a real-time feed of all Orion Oyj filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Orion Oyj via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK